AVIR icon

Atea Pharmaceuticals

125 hedge funds and large institutions have $327M invested in Atea Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 15 closing their positions.

Holders
125
Holders Change
-1
Holders Change %
-0.79%
% of All Funds
2.16%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
16
Increased
50
Reduced
34
Closed
15
Calls
$13.4M
Puts
$540K
Net Calls
+$12.8M
Net Calls Change
-$208K
Name Holding Trade Value Shares
Change
Shares
Change %
PAM
126
Panagora Asset Management
Massachusetts
-$164K -23,032 Closed
Two Sigma Advisers
127
Two Sigma Advisers
New York
-$155K -21,800 Closed
William Blair & Company
128
William Blair & Company
Illinois
-$103K -14,439 Closed
Arrowstreet Capital
129
Arrowstreet Capital
Massachusetts
-$77K -10,878 Closed
PCM
130
Prelude Capital Management
New York
-$72K -10,196 Closed
GWM
131
Geneos Wealth Management
Colorado
-$7K -1,000 Closed
SC
132
SouthState Corp
Florida
-$4K -565 Closed
CAPTRUST Financial Advisors
133
CAPTRUST Financial Advisors
North Carolina
-$4K -502 Closed